New PPARα Agonist A190-Loaded Microemulsion for Chemotherapy-Induced Peripheral Neuropathy

Keyphrases

• Peroxisome Proliferator-activated Receptor 100%
• Chemotherapy-induced Peripheral Neuropathy 100%
• Microemulsion 100%
• Alpha Agonist 100%
• Oral Bioavailability 42%
• Microemulsion Formulation 28%
• Cell Viability 14%
• Preventive Intervention 14%
• Non-opioid 14%
• Anticancer Agents 14%
• Physical Stability 14%
• Evoked Pain 14%
• Fenofibrate 14%
• Orally Administered 14%
• Clinical Utility 14%
• Therapeutic Intervention 14%
• Therapeutic Efficacy 14%
• Chronic Inflammatory Diseases 14%
• Droplet Size 14%
• Highly Selective 14%
• Hydrophobic Drugs 14%
• Drug Loading Capacity 14%
• Intestinal Permeability 14%
• Chronic Inflammatory Pain 14%
• Receptor Affinity 14%
• Freund Incomplete Adjuvant 14%
• Low Water Solubility 14%
• Box-Behnken Design 14%
• Effective Permeability 14%
• Neuroprotective Properties 14%
• Therapeutic Candidates 14%
• Apparent Permeability 14%
• Subtype Selectivity 14%
• High Biocompatibility 14%
• Analgesic Properties 14%
• Mechanical Hypersensitivity 14%
• Alpha Activation 14%
• Chemotherapy-induced Neuropathic Pain 14%
• Oral Therapeutics 14%
• Oil-in-water Microemulsion 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Peroxisome Proliferator Activated Receptor Alpha Agonist 100%
• Chemotherapy-Induced Peripheral Neuropathy 100%
• Microemulsions 100%
• Bioavailability 44%
• Chemotherapy 11%
• Erethism 11%
• Biocompatibility 11%
• Cell Viability 11%
• Neuropathic Pain 11%
• Receptor 11%
• Fenofibrate 11%
• Side Effect 11%
• Analgesic Agent 11%
• Intestinal Permeability 11%
• Chronic Inflammatory Pain 11%
• Peroxisome Proliferator Activated Receptor Alpha 11%
• Combination Therapy 11%
• Neuroprotective Agent 11%
• Freund's Adjuvant 11%
• Anticancer Drug 11%

Immunology and Microbiology

• Apparent Permeability 11%